319 related articles for article (PubMed ID: 2732120)
1. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
Rolston KV; LeBlanc B; Gooch G; Ho DH; Bodey GP
J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
Rolston KV; LeBlanc B; Ho DH; Bodey GP
J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1990; 36(5):365-72. PubMed ID: 2209169
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
Dholakia N; Rolston KV; Ho DH; LeBlanc B; Bodey GP
Antimicrob Agents Chemother; 1994 Apr; 38(4):848-52. PubMed ID: 8031057
[TBL] [Abstract][Full Text] [Related]
5. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
Hoban D; Grabowski M; Koss J; Weselowski V
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
Rolston KV; Nguyen H; Messer M; LeBlanc B; Ho DH; Bodey GP
Antimicrob Agents Chemother; 1990 Nov; 34(11):2263-6. PubMed ID: 2127348
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates.
Barry AL; Fuchs PC; Brown SD
Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.
Rolston KV; Ho DH; LeBlanc B; Gooch G; Bodey GP
Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):684-6. PubMed ID: 3143585
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Rolston K; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan.
Sheng WH; Wang JT; Chen YC; Chang SC; Luh KT
J Microbiol Immunol Infect; 2001 Sep; 34(3):178-84. PubMed ID: 11605808
[TBL] [Abstract][Full Text] [Related]
11. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.
Tanaka M; Yamazaki E; Chiba M; Yoshihara K; Akasaka T; Takemura M; Sato K
Antimicrob Agents Chemother; 2002 Mar; 46(3):904-8. PubMed ID: 11850285
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
Seifert H
Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
16. Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Prosser BL; Beskid G
Diagn Microbiol Infect Dis; 1995 Jan; 21(1):33-45. PubMed ID: 7789095
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial activity of the new quinolone Bay y3118 against clinical isolates.
Ravizzola G; Pizzi R; Pirali F; Turano A
J Chemother; 1994 Dec; 6(6):392-8. PubMed ID: 7699426
[TBL] [Abstract][Full Text] [Related]
18. Temafloxacin: in vitro comparison with five other antibacterial agents.
Digranes A; Hardardottir H; Bottolfsen KL
Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.
Bongaerts GP; Hoogkamp-Korstanje JA
Antimicrob Agents Chemother; 1993 Sep; 37(9):2017-9. PubMed ID: 8239624
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
Sonstein SA; Dahlgren J
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
